Gonda Masakazu

Affiliation and department：
Papers (29)：

Toshiki Etani, Chiharu Wachino, Takuya Sakata, Maria Aoki, Masakazu Gonda, Nobuhiko Shimizu, Takashi Nagai, Rei Unno, Kazumi Taguchi, Taku Naiki, et al. Using fosfomycin to prevent infection following ureterorenoscopy in response to shortage of cephalosporins: a retrospective preliminary study. BMC urology. 2024. 24. 1. 145-145
Teruki Isobe, Taku Naiki, Yosuke Sugiyama, Aya Naiki-Ito, Takashi Nagai, Toshiki Etani, Keitaro Iida, Yusuke Noda, Nobuhiko Shimizu, Maria Aoki, et al. Experience and prognostic analysis with avelumab switch maintenance treatment in metastatic urothelial carcinoma. Oncology. 2024
Toshiharu Morikawa, Taku Naiki, Yosuke Sugiyama, Aya Naiki-Ito, Takashi Nagai, Toshiki Etani, Keitaro Iida, Teruki Isobe, Yusuke Noda, Nobuhiko Shimizu, et al. C-Reactive Protein Is a Potential Prognostic Marker in Patient with Advanced or Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multi-Center Retrospective Study. Cancers. 2024. 16. 9
Teruki Isobe, Noriyasu Kawai, Maria Aoki, Toshiharu Morikawa, Masakazu Gonda, Nami Tomiyama, Takashi Nagai, Keitaro Iida, Toshiki Etani, Taku Naiki, et al. Late relapsing testicle cancer identified with isochromosome 12p (i12p) fluorescence in situ hybridization (FISH) analysis. Pathology international. 2024. 74. 3. 160-162
Keitaro Iida, Taku Naiki, Toshiki Etani, Takashi Nagai, Yosuke Sugiyama, Teruki Isobe, Maria Aoki, Satoshi Nozaki, Yusuke Noda, Nobuhiko Shimizu, et al. Proton pump inhibitors and potassium competitive acid blockers decrease pembrolizumab efficacy in patients with metastatic urothelial carcinoma. Scientific reports. 2024. 14. 1. 2520-2520

ｍore...

MISC (5)：

清水伸彦, 内木拓, 鬼頭拓未, 青木マリア, 坂田卓弥, 森川敏治, 権田将一, 水野健太郎, 安井孝周. 非筋層浸潤性膀胱癌の光力学診断における経口5-アミノレブリン酸誘発性低血圧の検討. 日本癌治療学会学術集会(Web). 2023. 61st
内木拓, 杉山洋介, 森川敏治, 磯部輝紀, 清水伸彦, 野田祐介, 永井隆, 惠谷俊紀, 青木マリア, 権田将一, et al. 転移性尿路上皮癌に対する3次治療施行症例の後方視的解析. 日本泌尿器科学会中部総会プログラム・抄録集. 2023. 73rd
青木マリア, 内木拓, 森川敏治, 磯部輝紀, 権田将一, 清水伸彦, 野田祐介, 永井隆, 阪野里花, 恵谷俊紀, et al. Maintenance of skeletal muscle in receiving neoadjuvant chemotherapy improves the prognosis for patients with muscle invasive bladder cancer. 日本泌尿器科学会総会(Web). 2023. 110th
内木拓, 内木拓, 内木拓, 杉山洋介, 田崎慶彦, 小松弘和, 惠谷俊紀, 青木マリア, 権田将一, 森川敏治, et al. 当院における前立腺神経内分泌癌の検証. 日本泌尿器科学会中部総会プログラム・抄録集. 2022. 72nd
青木マリア, 内木拓, 磯部輝紀, 権田将一, 冨山奈美, 清水伸彦, 野田祐介, 永井隆, 惠谷俊紀, 飯田啓太郎, et al. 術前化学療法前後における骨格筋変化量は膀胱全摘症例の予後予測因子である. 日本癌治療学会学術集会(Web). 2022. 60th

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page